Logan Lutton

A study using global health records reports that color-blind individuals face higher bladder cancer mortality, potentially due to delayed detection of blood in urine, while no similar survival difference is seen in colorectal cancer.

In 2024, U.S. health care spending rose to $5.3 trillion, driven by increased per capita use and demand for medical services as utilization rebounded following the COVID-19 pandemic.

A long-term UK Biobank analysis shows that while early or surgical menopause initially appears linked to higher diabetes rates, this association disappears after accounting for lifestyle and cardiovascular risk factors rather than menopause timing itself.

United States health care spending rose to $5.3 trillion in 2024, accounting for 18% of the economy, as strong post-pandemic demand and high insurance coverage continued to drive costs upward.

A recent study found that TikTok videos about breast cancer screening created by physicians are more accurate and reliable than those made by nonphysicians or private clinics, highlighting both the platform’s growing role in health education and persistent quality gaps.

A nationwide randomized study showed that risk-based breast cancer screening safely detects cancer while reducing unnecessary screening for low-risk women and is favored by most patients over annual mammograms.

Despite widespread exposure to breast cancer misinformation that heightened fear in many patients, a survey found it did not lead to increased treatment nonadherence.

Numerous medical societies and experts have labeled the CDC’s decision as dangerous and confusing.

In 2024, 91% of patients receiving care through the Ryan White HIV/AIDS Program were virally suppressed, underscoring the program’s role in improving HIV outcomes.

New guidelines from the Health Resources and Services Administration (HRSA) aim to reduce cost and access barriers for detecting human papillomavirus, which is preventable.

Universal recommendations dropped include vaccines for COVID-19 and flu shots.

Long-term Medicaid expansion was linked to substantial growth in PrEP prescribing, with earlier expansion states seeing far higher PrEP uptake relative to new HIV diagnoses, according to a recent study.

Here’s what you missed this week on Managed Healthcare Executive.

The Residual Transformer Generative Adversarial Network (RRTGAN) generates high-quality, cellular-level retinal images from minimal data inputs, overcoming the limitations of previous slow and burdensome imaging methods.

Kyverna’s investigational CAR-T therapy, mivocabtagene autoleucel (miv-cel) showed clinically meaningful mobility improvements in most stiff-person syndrome patients, prompting the company to plan an FDA BLA submission in 2026.

Falls among older adults with visual impairment are strongly linked to modifiable home hazards—especially broken flooring and tripping risks—while fall risk remains relatively low in hazard-free homes.

Despite widespread awareness of shingles risk factors, fewer than one-third of U.S. primary care physicians are fully aware of current ACIP shingles vaccine recommendations, highlighting the need for improved education and implementation.

A new influenza strain could fuel a severe flu season while a surge in measles cases threatens U.S. elimination status, emphasizing that vaccination remains critical to limiting disease spread and severity, according to faculty from Johns Hopkins Bloomberg School of Public Health.

Addyi is the first FDA-approved treatment for low libido in women ages 65 and younger.

A study of more than 1 million UK medical records found that getting a flu vaccine between ages 40 and 50 did not increase Parkinson’s disease risk and was even associated with a lower estimated prevalence eight years later, suggesting a possible protective effect that warrants further research.

Results from a recent ianalumab treatment trial signal a potential for longer-lasting disease control for patients with primary immune thrombocytopenia.

The CAR T Vision Steering Committee members wish to double the number of eligible patients receiving chimeric antigen receptor (CAR) T-cell therapy by 2030 through disease awareness and sustainable financing options, according to George Eastwood, Executive Director of the Emily Whitehead Foundation and recent CAR T Vision Steering Committee member.

Chimeric antigen receptor (CAR) T-cell therapy can cure certain types of blood cancer, but cost and a general lack of awareness around the therapy are barriers to care, according to George Eastwood, Executive Director of the Emily Whitehead Foundation.

In this interview, George Eastwood, Executive Director of the Emily Whitehead Foundation and CAR T Vision steering committee member discusses barriers and strategies for expanding access to CAR T-cell therapy.

Here’s what you missed this week on Managed Healthcare Executive.

About one-third of families with a child undergoing treatment for acute lymphoblastic leukemia experienced catastrophic income loss during therapy, with many developing new material hardships over the two-year course, underscoring the need for ongoing financial screening and support.

IV iron infusions were found to be safe for anemic patients hospitalized with acute bacterial infections and were associated with improved survival and higher hemoglobin levels, challenging long-held concerns that iron worsens infections.

Multiple sclerosis patients who completed hydrotherapy courses had better symptom outcomes than patients who participated in physical therapy sessions on land.

Self-administered clinical hypnosis cut hot flash frequency and severity by more than 50% in postmenopausal women, showing effectiveness comparable to therapist-led treatment in a recent randomized trial.

In this interview, Susan Kellogg-Spadt, Ph.D., the director of female sexual medicine at the Center for Pelvic Medicine at Academic Urology of PA, discusses common menopausal sexual issues and how the culture around ageism and taboo is changing.